Suppr超能文献

病理分期为II期和III期结肠癌患者腹腔镜手术的短期和长期结果

Short- and long-term outcomes of laparoscopic surgery in patients with pathological stage II and III colon cancer.

作者信息

Nakamura Takatoshi, Mitomi Hiroyuki, Onozato Wataru, Sato Takeo, Ikeda Atsushi, Naito Masanori, Ogura Naoto, Kamata Hiroki, Ooki Akira, Watanabe Masahiko

机构信息

Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan.

出版信息

Hepatogastroenterology. 2011 Nov-Dec;58(112):1947-50. doi: 10.5754/hge11196.

Abstract

BACKGROUND/AIMS: In Japan, the safety and long-term outcomes of laparoscopic surgery for advanced colorectal cancer remains a matter of debate. We studied the safety and outcomes of laparoscopic surgery in patients with pathological stage II and III colon cancer.

METHODOLOGY

The study group comprised 253 patients with colon cancer who underwent laparoscopic surgery from January 1998 through December 2006. We studied surgical outcomes, invasiveness, safety, recurrence rates, recurrence patterns, and long-term outcomes.

RESULTS

Median follow-up was 67 months (range, 7-149). Laparoscopic surgery was converted to open surgery in 5 patients (2%). Postoperative complications occurred in 23 patients (9%); wound infections were most common (11 patients, 4.3%), followed by ileus (5 patients, 1.9%). Recurrence developed in 66 patients (26%). Liver and lung metastases were the most common types of recurrence; there was no port-site recurrence. The 10-year recurrence-free survival rate and the overall survival rate were respectively 92.9% and 93.3% in stage II disease, 82.7% and 82.9% in stage IIIA and IIIB disease, and 70.3% and 68.6% in stage IIIC disease.

CONCLUSIONS

In patients with pathological stage II and III colon cancer, laparoscopic surgery is safe, minimally invasive, and has good surgical outcomes, overall survival rates and recurrence-free survival rates. Our results suggest that laparoscopic surgery is a viable treatment option for pathological stage II and III colon cancer.

摘要

背景/目的:在日本,晚期结直肠癌腹腔镜手术的安全性和长期疗效仍存在争议。我们研究了病理分期为II期和III期结肠癌患者腹腔镜手术的安全性和疗效。

方法

研究组包括1998年1月至2006年12月期间接受腹腔镜手术的253例结肠癌患者。我们研究了手术疗效、侵袭性、安全性、复发率、复发模式和长期疗效。

结果

中位随访时间为67个月(范围7 - 149个月)。5例患者(2%)腹腔镜手术转为开腹手术。23例患者(9%)发生术后并发症;伤口感染最为常见(11例,4.3%),其次是肠梗阻(5例,1.9%)。66例患者(26%)出现复发。肝转移和肺转移是最常见的复发类型;无切口种植转移。II期疾病的10年无复发生存率和总生存率分别为92.9%和93.3%,IIIA期和IIIB期疾病分别为82.7%和82.9%,IIIC期疾病分别为70.3%和68.6%。

结论

对于病理分期为II期和III期的结肠癌患者,腹腔镜手术安全、微创,具有良好的手术疗效、总生存率和无复发生存率。我们的结果表明,腹腔镜手术是病理分期为II期和III期结肠癌的一种可行治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验